4K6-29527-05641
2 vaccinations
1 coded response
17 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 070 / NJ
- Registered
- 2021-04-07
- Relationship
- Self
- Race
- Asian
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-07
Registered in v-safe
-
2021-04-07
Dose 1 — Janssen/Johnson & Johnson
- 2021-04-07
-
2021-04-08
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-04-09
- 2021-04-10
-
2021-04-12
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Chills, Fatigue or tiredness, NauseaAdult check-in
- 2021-04-13
- 2021-04-14
- 2021-04-21
- 2021-04-28
- 2021-07-07
- 2021-10-08
-
2021-10-28
Dose 2 — Pfizer-BioNTech
-
2021-11-01
Survey response — days 1–6 daily, dose 2MedDRA: Oropharyngeal pain — Feeling: Fair · Fever · Fatigue or tirednessFree text: Sore ThroatMedDRA releases: 2024-11 · check-in free text available
- 2021-11-04
- 2021-11-11
- 2021-11-25
- 2021-12-02
- 2021-12-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-07 | Janssen/Johnson & Johnson | |
| 2 | 2021-10-28 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Sore Throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release